Chinese Clinical Practice Guideline on Management of Crohn's Disease(2023,Guangzhou)
10.3969/j.issn.1008-7125.2024.04.002
- VernacularTitle:中国克罗恩病诊治指南(2023年·广州)
- Author:
Inflammatory Bowel Disease Group,Chinese Society of Gastroenterology,Chinese Medical Association
1
;
Inflammatory Bowel Disease Quality Control Center of China
;
Minhu CHEN
;
Kaichun WU
Author Information
1. 中山大学附属第一医院消化内科(510080)
- Keywords:
Crohn Disease;
Guideline;
GRADE Approach;
Delphi Technique
- From:
Chinese Journal of Gastroenterology
2024;29(4):200-235
- CountryChina
- Language:Chinese
-
Abstract:
Crohn's disease(CD)is a complex condition spanning multiple disciplines.Standardized diagnostics and treatment are paramount for enhancing the therapeutic efficacy and improving the prognosis of CD.In recent years,substantial progress has been achieved in both basic and clinical research on CD in China.The integration of novel diagnostic and therapeutic paradigms,new treatment modalities,have necessitated the update of consensus on CD management,offering imperative,evidence-based guidelines for health providers.This guideline,collaboratively developed by the Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology,Chinese Medical Association,and the Inflammatory Bowel Disease Quality Control Center of China,incorporates the latest international consensus,domestic research findings,and practical considerations,as an update based on the 2018 Chinese consensus on diagnosis and treatment in inflammatory bowel disease.The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of CD,providing standardized guidance for the clinical management of CD.
